Ani Pharmaceuticals (ANIP) Other financing activities (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted Other financing activities of $2.2 million for Q1 2026, up 5694.74% sequentially from $38000.0 in Q4 2025, and down 13.1% YoY from $2.5 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Other financing activities (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Other financing activities for 15 years, with the latest figure at $2.2 million in Q1 2026.
- Quarterly Other financing activities fell 13.1% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 106.38% YoY) and the FY2025 annual result came in at $13.6 million, up 109.68% from the prior year.
- Other financing activities advanced to $2.2 million in Q1 2026 per ANIP's latest filing, from $38000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $9.8 million in Q3 2025 and troughed at $3000.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $1.2 million in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2023 and 2025: Other financing activities surged 5133.33% in 2023, then sank 97.76% in 2025.
- Over 5 years, Other financing activities stood at $768000.0 in 2022, then jumped by 156.38% to $2.0 million in 2023, then decreased by 13.66% to $1.7 million in 2024, then tumbled by 97.76% to $38000.0 in 2025, then surged by 5694.74% to $2.2 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $2.2 million, $38000.0, and $9.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 308,000.00 |
| Jun 30, 2026 | 308,000.00 |
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 38,000.00 |
| Dec 31, 2025 | 38,000.00 |
| Sep 30, 2025 | 9.79 Mn |
| Sep 30, 2025 | 9.79 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |